|
|
||||||||
Articles |
Department of Radiology, Karl-Franzens-University Graz, Medical School, Austria.
MR of the brain was performed in eight patients (mean age, 14.9 years) with osteogenic sarcoma during or after IV treatment with high-dose methotrexate. MR detected brain abnormalities in four patients, three of whom had concomitant neurologic dysfunction. Pathologic findings demonstrated on MR were (1) chronic brain edema, demonstrable over a period of 3-14 months (proved by autopsy in one patient); (2) multifocal white matter necrosis; and (3) deep brain atrophy. MR appears to be valuable in the detection of abnormalities induced by treatment with high-dose methotrexate.
This article has been cited by other articles:
![]() |
A. F. Eichler, T. T. Batchelor, and J. W. Henson Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate Neuro-oncol, July 1, 2007; 9(3): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C.A. Steens, G. M. Steup-Beekman, G. P.Th. Bosma, F. Admiraal-Behloul, H. Olofsen, J. Doornbos, T. W.J. Huizinga, and M. A. van Buchem The Effect of Corticosteroid Medication on Quantitative MR Parameters of the Brain AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2475 - 2480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kitahara, S. Nakasu, K. Murata, K. Sho, and R. Ito Evaluation of Treatment-Induced Cerebral White Matter Injury by Using Diffusion-Tensor MR Imaging: Initial Experience AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2200 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fliessbach, H. Urbach, C. Helmstaedter, H. Pels, A. Glasmacher, J. A. Kraus, T. Klockgether, I. Schmidt-Wolf, and U. Schlegel Cognitive Performance and Magnetic Resonance Imaging Findings After High-Dose Systemic and Intraventricular Chemotherapy for Primary Central Nervous System Lymphoma Arch Neurol, April 1, 2003; 60(4): 563 - 568. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |